Overview
Virtual Patient: Improving Outcomes in Multiple Sclerosis
Click the"View Activity" button to view this activity.
View ActivityCME/CE is no longer available for this activity
This educational activity is designed for physicians and other clinicians who manage and treat patients with MS.
Clinicians treating patients with Multiple Sclerosis(MS) face two main obstacles: 1. a lack of current guidelines and 2. limited clinical experience with risks and benefits of newer and emerging agents. Thus, additional training to optimally assess the risks and benefits of MS therapies and the utilization of imaging and other instruments in practice to better assess and manage patients with MS is necessary and would enhance clinical abilities in the selection of appropriate diagnostic tests, therapies, and use of symptom management strategies for patients with MS.
Upon completion of this activity, participants should be able to
- Examine the basic tenets of MS immunology and recognize the scientific factors supporting the clinical management of MS
- Adopt improved diagnostic and assessment approaches in MS management that utilize advances in imaging technology and other screening tools
- Discuss the goals of MS treatment with patients to implement clinical algorithms for initial disease management and improve outcomes
- Formulate and monitor treatment strategies for MS based on patient characteristics and preferences
- Evaluate the safety and efficacy of pharmacologic treatment approaches for disease modification and symptom management
Sponsored by The Academy for Continued Healthcare Learning
Supported by an educational grant from Novartis Pharmaceuticals Corporation
Bruce A. Cohen, MD
Professor of Neurology
Davee Department of Neurology and Clinical Neurosciences
Feinberg School of Medicine
Northwestern University
Director Comprehensive Multiple Sclerosis Program
Northwestern Medical Faculty Foundation
Chicago, Illinois
Professor of Neurology
Davee Department of Neurology and Clinical Neurosciences
Feinberg School of Medicine
Northwestern University
Director Comprehensive Multiple Sclerosis Program
Northwestern Medical Faculty Foundation
Chicago, Illinois
The Academy for Continued Healthcare Learning (ACHL) requires that the faculty participating in a CME/CE activity disclose all affiliations or other financial relationships (1) with the manufacturers of any commercial product(s) and/or provider(s) of commercial services discussed in an educational presentation and (2) with any commercial supporters of the activity. All conflicts of interest have been resolved prior to this CME/CE activity. ACHL also requires participating faculty to disclose when unapproved/unlabeled uses of a product are discussed in a CME/CE activity.
This CME activity might describe the off-label, investigational, or experimental use of medications that may exceed their FDA-approved labeling. Physicians should consult the current manufacturers’ prescribing information for these products. ACHL requires the speaker to disclose that a product is not labeled for the use under discussion. The provider’s documentation of common practices that make the disclosure requirement known to faculty demonstrates compliance with ACCME guidelines.
Bruce Cohen, MD (Chair) Type of financial relationships:
Sources of Funding for Research: Through Northwestern University-Biogen Idec, Hoffman La-Roche, Novartis
Consulting Agreements: Acorda, Astellas, Biogen Idec, EMD Serono, Teva Neuroscience, Genzyme, sanofi-aventis
Financial Interests/Stock Ownership: Abbott, CVS-Caremark
Discussion of Off-Label, Investigational, or Experimental Drug Use: None
This CME activity might describe the off-label, investigational, or experimental use of medications that may exceed their FDA-approved labeling. Physicians should consult the current manufacturers’ prescribing information for these products. ACHL requires the speaker to disclose that a product is not labeled for the use under discussion. The provider’s documentation of common practices that make the disclosure requirement known to faculty demonstrates compliance with ACCME guidelines.
Bruce Cohen, MD (Chair) Type of financial relationships:
Sources of Funding for Research: Through Northwestern University-Biogen Idec, Hoffman La-Roche, Novartis
Consulting Agreements: Acorda, Astellas, Biogen Idec, EMD Serono, Teva Neuroscience, Genzyme, sanofi-aventis
Financial Interests/Stock Ownership: Abbott, CVS-Caremark
Discussion of Off-Label, Investigational, or Experimental Drug Use: None
The Academy for Continued Healthcare Learning staff members and others involved with the planning, development, and review of the content for this activity have no relevant affiliations or financial relationships to disclose.
This activity utilizes a digital platform that enables learners to explore three patient profiles (case-based learning) that present some of the challenges clinicians may encounter when treating patients with MS. It has been determined that this online activity can be completed in 45 minutes. To receive credit, participants must complete the preassessment survey, review the learning objectives and faculty disclosures, view all three patient profiles, reflect on the content, achieve 75% on the postassessment survey and complete the evaluation. A certificate of credit will be immediately available once these requirements are met. There is no fee to participate in the program or for the generation of the certificate.
Hardware and Software Requirements |
An active Internet connection (DSL or Cable). A wireless, dial-up, or slow connection may have constant buffering problems. Windows
Mac OS
|
The Academy for Continued Healthcare Learning is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. |
The Academy for Continued Healthcare Learning designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. |